Abstract
Magnetic resonance image (MRI) processing pipelines use average templates to enable standardization of individual MRIs in a common space. MNI-ICBM152 is currently used as the standard template by most MRI processing tools. However, MNI-ICBM152 represents an average of 152 healthy young adult brains and is vastly different from brains of patients with neurodegenerative diseases. In those populations, extensive atrophy might cause inevitable registration errors when using an average template of young healthy individuals for standardization. Disease-specific templates that represent the anatomical characteristics of the populations can reduce such errors and improve downstream driven estimates.
We present multi-sequence average templates for Alzheimer’s Dementia (AD), Fronto-temporal Dementia (FTD), Lewy Body Dementia (LBD), Mild Cognitive Impairment (MCI), cognitively intact and impaired Parkinson’s Disease patients (PD-CIE and PD-CI, respectively), individuals with Subjective Cognitive Impairment (SCI), AD with vascular contribution (V-AD), Vascular Mild Cognitive Impairment (V-MCI), Cognitively Intact Elderly (CIE) individuals, and a human phantom. We also provide separate templates for males and females to allow better representation of the diseases in each sex group.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MD is supported by a scholarship from the Canadian Consortium on Neurodegeneration in Aging (CCNA) as well as by an Alzheimer Society Research Program (ASRP) postdoctoral award. CCNA is supported by a grant from the Canadian Institutes of Health Research with funding from several partners.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The COMPASS-ND study was approved by the Jewish General Hospital Research Ethics Board. Written informed consent was obtained from all participants.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
rcamicio{at}ualberta.ca
simon.duchesne{at}fmed.ulaval.ca
Data Availability
The average template files for all groups and sequences are available in both compressed MINC and NIfTI formats at G-Node (https://gin.g-node.org/mahsadadar/CDIP_Templates) as well as Zenodo (https://zenodo.org/record/5018356#.YNPNkExE3b0).
Abbreviations
- AD
- Alzheimer’s Dementia
- CIE
- Cognitively Intact Elderly
- FLAIR
- FLuid Attenuated Inversion Recovery
- FTD
- Fronto-temporal Dementia
- LBD
- Lewy Body Dementia
- MCI
- Mild Cognitive Impairment
- MRI
- Magnetic Resonance Imaging
- PD
- Parkinson’s Disease
- PD
- Proton Density
- SCI
- Subjective Cognitive Impairment
- T1w
- T1-weighted
- T2w
- T2-weighted
- TE
- echo time
- TI
- inversion time
- TR
- repetition time
- V-AD
- Vascular Alzheimer’s Dementia
- V-MCI
- Vascular Mild Cognitive Impairment
- WMH
- White Matter Hyperintensity
